LY2275796
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY2275796, covering 2012-07-30 to 2012-07-30. Get the full timeline:
Most recent: Clinical Trial Update: LY2275796 in Advanced Cancer [Phase 1]
1 regulatory and trial event tracked for LY2275796, covering 2012-07-30 to 2012-07-30. Get the full timeline:
Most recent: Clinical Trial Update: LY2275796 in Advanced Cancer [Phase 1]